## **Core Concept**
Meningococcal meningitis is a severe infection caused by *Neisseria meningitidis*, requiring prompt antibiotic treatment. Penicillin is a first-line treatment, but for patients allergic to penicillin, alternative antibiotics must be used. The management involves selecting an effective antibiotic that can cross the blood-brain barrier.
## **Why the Correct Answer is Right**
The correct answer, Ceftriaxone, is a third-generation cephalosporin with potent activity against *Neisseria meningitidis*. It can cross the blood-brain barrier, achieving high concentrations in the cerebrospinal fluid, making it effective for treating meningitis. Ceftriaxone is also well-tolerated and has a broad spectrum of activity, which is beneficial in cases where the causative organism is not yet identified.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Chloramphenicol is an alternative for treating meningitis but is less commonly used today due to its side effect profile, including aplastic anemia. It's not the first choice for penicillin-allergic patients.
- **Option B:** Ciprofloxacin is a fluoroquinolone with broad-spectrum activity but is not typically used as a first-line treatment for meningococcal meningitis, especially in severe cases or when other effective options are available.
- **Option D:** Vancomycin is used for treating infections caused by Gram-positive bacteria and is not effective against *Neisseria meningitidis*, which is a Gram-negative organism.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for patients with suspected or confirmed meningococcal meningitis who are allergic to penicillin, ceftriaxone or cefotaxime are preferred alternatives. These cephalosporins are generally safe to use in patients with a history of penicillin allergy, provided they do not have a known allergy to cephalosporins.
## **Correct Answer:** C. Ceftriaxone.
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.